Post Profile

Three anticoagulant studies may change current medical practice

New research reveals that the practice of using the anticoagulants aspirin and heparin with the hope of preventing clots in placental blood vessels is ineffective for preventing unexplained, recurrent miscarriages. Two other studies look at treatments for venous thromboembolism, a common and sometimes deadly clotting disorder.
read more


Related Posts:

Can Polypectomy Be Performed Without Interruption Of Anticoagulation?

Health : Medical News Today (6 years ago)

Currently, patients taking anticoagulants to prevent stroke and blood clots are often recommended to stop these medications in order to perform colonoscopy with removal of polyps. However, interruption of these medications can place... Read Post

Bayer's Novel Anticoagulant Rivaroxaban Recommended For EU Approval - Venous Blood Clot Prevention After Elective Hip Or Knee Replacement Surgery

Health : Medical News Today (7 years ago)

The European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of the anticoagulant rivaroxaban (Xarelto®), taken as one tablet, once-daily, for the prevention of venous blood clots (deep vein thrombosis... Read Post

Three Anticoagulant Studies May Change Current Medical Practice

Health : Medical News Today (5 years ago)

Blood clotting, or coagulation, is an important process that prevents excessive bleeding when a blood vessel is injured. Sometimes, however, clots form on the inside of vessels without an obvious injury or do not dissolve naturally,... Read Post


Copyright © 2015 Regator, LLC